Magnetic heart scan may spot rare disease earlier

NCT ID NCT07218705

First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 20 times

Summary

This study tests whether a new, non-invasive heart scan called magnetocardiography (MCG) can help doctors find and monitor amyloidosis, a rare disease where abnormal proteins build up in organs. Researchers will compare MCG results with standard ECG in 500 adults. This is an observational study, meaning no treatment is given—just measurements to see if MCG works better for diagnosis and tracking.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mayo Clinic in Rochester

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.